
After studying this material, you should be able to:
Normal Blood Pressure: < 120/80 mmHg
Elevated: 120-129 / < 80 mmHg
Hypertension Stage 1: 130-139 / 80-89 mmHg
Hypertension Stage 2: ≥ 140 / ≥ 90 mmHg
| Feature | Explanation |
|---|---|
| No obvious symptoms | People feel fine while damage accumulates |
| Delayed diagnosis | Found only during incidental screening |
| Consequences | Stroke, heart failure, kidney damage |
| Scale | Affects 1 billion+ people globally |
People with hypertension
│
▼
~50% unaware ◄─── This is the critical gap
│
▼
No treatment → Organ damage over years
⚠️ Key Insight: The problem is NOT that we lack treatments — it's that people don't know they need them, especially adults aged 18–44
METHOD 1: Office Blood Pressure Measurement
┌─────────────────────────────────────────┐
│ ✅ Gold standard for initial screening │
│ ❌ Episodic (only when you visit) │
│ ❌ "White coat effect" can skew results │
└─────────────────────────────────────────┘
METHOD 2: 24-Hour Ambulatory BP Monitoring (ABPM)
┌─────────────────────────────────────────┐
│ ✅ TRUE clinical gold standard │
│ ✅ Captures real-world BP patterns │
│ ❌ Expensive, inconvenient │
│ ❌ Not widely accessible │
└─────────────────────────────────────────┘
METHOD 3: Existing Cuffless Wearables
┌─────────────────────────────────────────┐
│ ✅ Convenient, passive │
│ ❌ Require regular cuff calibration │
│ ❌ Only track RELATIVE changes │
│ ❌ Cannot identify absolute hypertension│
└─────────────────────────────────────────┘
🎯 The Gap: We need something passive, scalable, and calibration-free that can identify absolute hypertensive states
How it works:
┌──────────────────────────────────────────┐
│ LED light shines into skin │
│ ↓ │
│ Blood absorbs light differently │
│ depending on pulse volume │
│ ↓ │
│ Sensor detects light reflection changes │
│ ↓ │
│ Creates a waveform of your pulse │
└──────────────────────────────────────────┘
What it reveals about BP:
• Pulse wave shape
• Arterial stiffness signals
• Vascular resistance patterns
How it works:
┌──────────────────────────────────────────┐
│ Detects tiny physical movements │
│ ↓ │
│ Captures Ballistocardiogram (BCG) │
│ = micro-movements caused by │
│ heart pumping blood │
└──────────────────────────────────────────┘
What it reveals about BP:
• Mechanical cardiac function
• Force of blood ejection
• Complementary to PPG signals
💡 Why Both? PPG captures vascular signals; ACC captures mechanical cardiac signals. Together they provide richer information than either alone — hence "multimodal"
STAGE 1: FEATURE LEARNING (Self-Supervised)
═══════════════════════════════════════════
Raw Data Input:
492,347 hours of sensor data
from 2,109 participants
(NO medical labels needed)
│
▼
┌─────────────────────────────────┐
│ 1-D Deep Convolutional │
│ Neural Network │
│ │
│ Analyzes 15-second windows │
│ of PPG + ACC simultaneously │
└─────────────────────────────────┘
│
▼
Contrastive Learning Objective:
"Windows from the SAME person
→ map CLOSE together in space"
"Windows from DIFFERENT people
→ map FAR apart in space"
│
▼
Result: Rich physiological
"embeddings" (feature vectors)
capturing vascular + cardiac patterns
STAGE 2: CLASSIFICATION
═══════════════════════════════════════════
Many 15-second embeddings per person
│
▼
Mean Aggregation
(average across days)
Purpose: "Wash out" noise from:
• Sudden movements
• Temperature changes
• Activity bursts
│
▼
Person-Level Embedding
+
User's Height
(proxy for arterial path length —
taller person = longer arteries =
different pulse wave timing)
│
▼
┌─────────────────────────────────┐
│ Regularized Logistic │
│ Regression Classifier │
└─────────────────────────────────┘
│
▼
Hypertension Probability Score
(0 to 1)
Taller person:
Heart → Wrist = LONGER distance
│
▼
Pulse wave takes LONGER to travel
│
▼
Affects timing features in waveform
│
▼
Height corrects for this variation
True Positive (TP): System says hypertensive → Actually hypertensive ✅
True Negative (TN): System says normal → Actually normal ✅
False Positive (FP): System says hypertensive → Actually normal ❌
False Negative (FN): System says normal → Actually hypertensive ❌
SENSITIVITY = TP / (TP + FN)
"Of all people WHO HAVE hypertension,
how many did we CATCH?"
→ High sensitivity = fewer missed cases
SPECIFICITY = TN / (TN + FP)
"Of all people WITHOUT hypertension,
how many did we correctly CLEAR?"
→ High specificity = fewer false alarms
PPV (Positive Predictive Value) = TP / (TP + FP)
"If the system flags someone,
how likely are they ACTUALLY hypertensive?"
→ High PPV = trustworthy positive results
| Method | Sensitivity | Specificity | PPV |
|---|---|---|---|
| AI Smartwatch | 65.8% | 90.0% | 80.6% |
| Office BP | 55.3% | — | 77.8% |
📊 Interpretation: The smartwatch catches MORE hypertensive people (65.8% vs 55.3%) with FEWER false alarms (PPV 80.6% vs 77.8%) compared to standard office screening
| Method | Sensitivity | Specificity | PPV |
|---|---|---|---|
| AI Smartwatch | 78.4% | 90.9% | 96.7% |
| Return Office Visit | 67.6% | 63.6% | 86.2% |
| Home Monitoring | 89.2% | 81.8% | 94.3% |
📊 Interpretation:
- Smartwatch outperforms return office visits on ALL metrics
- Smartwatch is competitive with multi-day home monitoring
- PPV of 96.7% means: if the smartwatch confirms hypertension, there's a 96.7% chance it's real
PPG WAVEFORM LANDMARKS:
─────────────────────────────────────────
ons = pulse onset (start of heartbeat)
sys = systolic peak (maximum pressure)
dic = dicrotic notch (aortic valve closes)
dia = diastolic peak (reflected wave)
In hypertension, you typically see:
• Higher amplitude systolic peak
• Earlier/more prominent dicrotic notch
• Stiffer waveform shape
• Altered timing between landmarks
BCG (Accelerometer) WAVEFORM LANDMARKS:
─────────────────────────────────────────
H, I, J, K, L, M, N waves
These reflect the MECHANICAL FORCES
of blood being pumped through the body.
Hypertension alters these force patterns.
SECOND DERIVATIVE OF PPG:
─────────────────────────────────────────
a, b, c, d, e waves
Amplifies subtle changes in waveform
shape that are invisible in raw signal.
Highly sensitive to arterial stiffness.
🔬 Key Finding: The AI learned these physiological differences automatically through contrastive learning — without being explicitly programmed to look for them
CURRENT WORKFLOW:
─────────────────────────────────────────
Person feels fine
│
▼ (years may pass)
Incidental office visit
│
▼
BP measured → Hypertension detected
│
▼
Treatment begins (often late)
PROPOSED WORKFLOW WITH SMARTWATCH:
─────────────────────────────────────────
Person wears smartwatch daily (passive)
│
▼
AI continuously analyzes PPG + ACC
│
▼
High hypertension probability detected
│
▼
User prompted: "Consider seeing a doctor"
│
▼
Office visit → Formal diagnosis
│
▼
Treatment begins EARLIER
✅ IS: ❌ IS NOT:
─────────────────────────────────────────────
Passive screening tool Diagnostic device
Opportunistic detection Replacement for cuff
Scalable population tool Standalone medical tool
Early warning system Exact BP measurement
Complement to clinical care Clinical decision maker
Study Type: Prospective, multi-center
Sites: 5 US locations
Participants: 196 diverse adults
Exclusions: Known cardiovascular disease,
BP medications
Gold Standard Used: 24-hour ABPM
(the most rigorous clinical benchmark)
| Design Choice | Why It Matters |
|---|---|
| Multi-center | Reduces site-specific bias |
| Diverse participants | Improves generalizability |
| ABPM as gold standard | Most rigorous comparison possible |
| No medication users | Clean signal, no confounders |
| Prospective design | Forward-looking, reduces selection bias |
PROBLEM:
1 billion+ people have hypertension
50%+ don't know it
→ Silent damage accumulates
EXISTING SOLUTIONS FALL SHORT:
Office visits: episodic, miss many cases
Cuffless wearables: need calibration
NEW SOLUTION (AI-PPG-ACC-HTN):
Uses PPG + ACC from consumer smartwatch
↓
Self-supervised AI learns physiological
signatures of hypertension
↓
Aggregates signals over days (reduces noise)
↓
Outputs hypertension probability score
↓
Performance comparable to clinical workflows
IMPACT:
Passive, scalable, calibration-free screening
→ Prompts at-risk people to seek care
→ Earlier diagnosis
→ Reduced cardiovascular damage
💡 Answers: Review Steps 2, 5, 4, 3, and 5 respectively to verify your understanding